Lv1
70 积分 2023-01-10 加入
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
4天前
已完结
Preclinical evaluation of efficacy and cytokine release of bispecific T cell engagers in humanized NSG mice
2个月前
已关闭
ABS0200 KT501, A CD19, BCMA-DIRECTED T-CELL ENGAGER (TCE), LEADS TO DEEP B-CELL DEPLETION AND MINIMAL CYTOKINE RELEASE IN VIVO
3个月前
已关闭
A transgenic mouse that spontaneously develops pathogenic TSH receptor antibodies will facilitate study of antigen-specific immunotherapy for human Graves’ disease
4个月前
已完结
Mouse model of Graves' ophthalmopathy induced by the immunization with TSHR A and IGF-1R[alpha] subunit gene
5个月前
已关闭
Characterization of the in vitro and in vivo properties of CFZ533, a blocking and non-depleting anti-CD40 monoclonal antibody
5个月前
已完结
Development and application of animal models to study thyroid-associated ophthalmopathy
5个月前
已完结
Trispecific anti-CD3/BCMA/CD38 antibodies for multiple myeloma: a patent evaluation of US20240132615
7个月前
已完结
Trispecific anti-CD3/BCMA/CD38 antibodies for multiple myeloma: a patent evaluation of US20240132615
7个月前
已完结
Proximity between LAG-3 and the T cell receptor guides suppression of T cell activation and autoimmunity
8个月前
已完结
皖公网安备34019202002308
